Total Payments
$505.76
2023 Payments
$50.79
Companies
8
Transactions
27
Medicare Patients
2,261
Medicare Billing
$315,878
Payment Breakdown by Category
Food & Beverage$505.76 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $505.76 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $186.81 | 7 | $0 (2019) |
| PFIZER INC. | $109.60 | 8 | $0 (2018) |
| ABBVIE INC. | $82.80 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $71.70 | 5 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $16.56 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $13.80 | 1 | $0 (2019) |
| Novo Nordisk Inc | $12.57 | 1 | $0 (2017) |
| Inari Medical, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $50.79 | 1 | ABBVIE INC. ($50.79) |
| 2022 | $32.67 | 2 | Janssen Pharmaceuticals, Inc ($32.67) |
| 2021 | $70.29 | 5 | AbbVie Inc. ($32.01) |
| 2020 | $12.67 | 1 | Janssen Pharmaceuticals, Inc ($12.67) |
| 2019 | $156.82 | 5 | Allergan Inc. ($143.02) |
| 2018 | $79.40 | 6 | PFIZER INC. ($57.03) |
| 2017 | $103.12 | 7 | PFIZER INC. ($52.57) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $50.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/06/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: VTE | ||||||
| 03/07/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $116.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/13/2018 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: METABOLIC DISEASE | ||||||
| 11/20/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/28/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/24/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/28/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/21/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Diabetes | ||||||
| 11/09/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/21/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 529 | 770 | $584,867 | $73,029 |
| 2022 | 8 | 518 | 760 | $530,893 | $63,705 |
| 2021 | 9 | 615 | 919 | $719,608 | $87,642 |
| 2020 | 7 | 599 | 905 | $719,050 | $91,502 |
Total Patients
2,261
Total Services
3,354
Medicare Billing
$315,878
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 135 | 144 | $96,480 | $12,196 | 12.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 75 | 79 | $91,719 | $11,683 | 12.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 34 | 53 | $74,200 | $9,378 | 12.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 123 | $55,473 | $7,083 | 12.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 33 | 34 | $15,402 | $1,960 | 12.7% |
About Dr. Kenneth Parks, MD
Dr. Kenneth Parks, MD is a Emergency Medicine healthcare provider based in Mamou, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952349078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Parks, MD has received a total of $505.76 in payments from pharmaceutical and medical device companies, with $50.79 received in 2023. These payments were reported across 27 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($505.76).
As a Medicare-enrolled provider, Parks has provided services to 2,261 Medicare beneficiaries, totaling 3,354 services with total Medicare billing of $315,878. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location Mamou, LA
- Active Since 06/02/2006
- Last Updated 05/27/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1952349078
Products in Payments
- VRAYLAR (Drug) $167.23
- XARELTO (Drug) $71.70
- AVYCAZ (Drug) $70.37
- CHANTIX (Drug) $62.62
- DALVANCE (Drug) $32.01
- ELIQUIS (Drug) $31.29
- ZERBAXA (Drug) $16.56
- ELELYSO (Drug) $15.69
- LOKELMA (Drug) $13.80
- Victoza (Drug) $12.57
- FLOWTRIEVER CATHETER, S (Device) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.